ARTICLE SUMMARY:
BioParadox is developing a new therapy paradigm for cardiovascular and vascular disease, beginning with patients suffering from claudication. The company has developed a patented formulation of platelet-rich-plasma (PRP) and a device for producing it from the patient’s own blood within minutes at the point of care.
BioParadox Inc. is developing new therapies for unmet needs in vascular and cardiovascular disease, beginning with patients suffering from intermittent claudication. The company has developed a patented formulation of PRP and a disposable device for producing it from a patient’s own blood within minutes at the point of care.
